Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14
Rhea-AI Summary
Kestra Medical Technologies (Nasdaq: KMTS), a wearable medical device and digital healthcare company, has scheduled its third quarter fiscal 2025 financial results announcement for Monday, April 14. The company will host a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time to discuss the results. Investors can access both live and archived versions of the webcast through the 'Events' section of the investor relations website, with registration recommended at least 10 minutes before the call.
Positive
- None.
Negative
- None.
News Market Reaction – KMTS
In the trading session that priced this news, KMTS declined 6.54%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report financial results for the third quarter fiscal 2025 on Monday, April 14. Management will host a corresponding conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time.
A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website. Participants are encouraged to register on the website at least 10 minutes prior to the start of the conference call.
About Kestra
Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.
Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com